User contributions
Jump to navigation
Jump to search
- 06:21, 25 October 2016 diff hist -644 m Acute promyelocytic leukemia Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:20, 25 October 2016 diff hist -1,472 m Rectal cancer Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:20, 25 October 2016 diff hist -276 m Urothelial carcinoma Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase I/II</span>" to "style="background-color:#EEEE00"|Phase I/II"
- 06:20, 25 October 2016 diff hist -92 m Hemophagocytic lymphohistiocytosis Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:19, 25 October 2016 diff hist -92 m Prostate cancer Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
- 06:18, 25 October 2016 diff hist -644 m Thyroid cancer Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:18, 25 October 2016 diff hist -92 m Osteosarcoma Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
- 06:18, 25 October 2016 diff hist -920 m Hepatocellular carcinoma Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:18, 25 October 2016 diff hist -92 m Gemtuzumab ozogamicin (Mylotarg) Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase I/II</span>" to "style="background-color:#EEEE00"|Phase I/II"
- 06:17, 25 October 2016 diff hist -920 m Aplastic anemia Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:17, 25 October 2016 diff hist -276 m Hodgkin lymphoma, nodular lymphocyte-predominant Text replacement - "<span style="background:#ff0000; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Retrospective</span>" to "style="background-color:#ff0000"|Retrospective"
- 06:17, 25 October 2016 diff hist -1,380 m Peripheral T-cell lymphoma Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:16, 25 October 2016 diff hist -184 m Transplant conditioning regimens Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:15, 25 October 2016 diff hist -184 m Endometrial cancer Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
- 06:15, 25 October 2016 diff hist -92 m Tositumomab and I-131 (Bexxar) Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:15, 25 October 2016 diff hist -92 m Light-chain (AL) amyloidosis Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:15, 25 October 2016 diff hist -92 m B-cell acute lymphoblastic leukemia Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Non-randomized</span>" to "style="background-color:#EEEE00"|Non-randomized"
- 06:15, 25 October 2016 diff hist -1,564 m Anaplastic glioma Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:15, 25 October 2016 diff hist -184 m Follicular lymphoma - historical Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:14, 25 October 2016 diff hist -552 m Anal cancer Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:14, 25 October 2016 diff hist -920 m Myelodysplastic syndrome Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:14, 25 October 2016 diff hist -92 m Acquired hemophilia A Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:13, 25 October 2016 diff hist -92 m Merkel cell carcinoma Text replacement - "<span style="background:#EEEE00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase II</span>" to "style="background-color:#EEEE00"|Phase II"
- 06:13, 25 October 2016 diff hist -276 m Chronic myeloid leukemia Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
- 06:13, 25 October 2016 diff hist -828 m Gastric cancer Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:13, 25 October 2016 diff hist -1,472 m Diffuse large B-cell lymphoma - historical Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:12, 25 October 2016 diff hist -828 m Levels of Evidence Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:12, 25 October 2016 diff hist -92 m Adult T-cell leukemia-lymphoma Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Randomized Phase II</span>" to "style="background-color:#00CD00"|Randomized Phase II"
- 06:11, 25 October 2016 diff hist -460 m Myelodysplastic syndrome Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:11, 25 October 2016 diff hist -276 m Acquired thrombotic thrombocytopenic purpura Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:10, 25 October 2016 diff hist -184 m Cutaneous T-cell lymphoma Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:10, 25 October 2016 diff hist -184 m Carcinoma of unknown primary Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:09, 25 October 2016 diff hist -1,748 m Soft tissue sarcoma Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 06:09, 25 October 2016 diff hist -368 m Ewing sarcoma Text replacement - "<span style="background:#00CD00; padding:3px 6px 3px 6px; border-color:black; border-width:2px; border-style:solid;">Phase III</span>" to "style="background-color:#00CD00"|Phase III"
- 04:13, 24 October 2016 diff hist 0 m Mantle cell lymphoma Text replacement - "back to top" to "back to top"
- 04:13, 24 October 2016 diff hist 0 m Diffuse large B-cell lymphoma Text replacement - "back to top" to "back to top"
- 04:12, 24 October 2016 diff hist 0 m Neuroendocrine tumor Text replacement - "back to top" to "back to top"
- 04:12, 24 October 2016 diff hist 0 m Hypereosinophilic syndrome Text replacement - "back to top" to "back to top"
- 04:12, 24 October 2016 diff hist 0 m Hairy cell leukemia Text replacement - "back to top" to "back to top"
- 04:12, 24 October 2016 diff hist 0 m Chronic myelomonocytic leukemia Text replacement - "back to top" to "back to top"
- 04:11, 24 October 2016 diff hist 0 m Follicular lymphoma Text replacement - "back to top" to "back to top"
- 04:10, 24 October 2016 diff hist 0 m Non-small cell lung cancer Text replacement - "back to top" to "back to top"
- 04:10, 24 October 2016 diff hist 0 m Style guide Text replacement - "back to top" to "back to top"
- 04:09, 24 October 2016 diff hist 0 m Large granular lymphocytic leukemia Text replacement - "back to top" to "back to top"
- 04:09, 24 October 2016 diff hist 0 m Light-chain (AL) amyloidosis Text replacement - "back to top" to "back to top"
- 04:09, 24 October 2016 diff hist 0 m Myelodysplastic syndrome Text replacement - "back to top" to "back to top"
- 04:08, 24 October 2016 diff hist 0 m Cutaneous T-cell lymphoma Text replacement - "back to top" to "back to top"
- 04:08, 24 October 2016 diff hist 0 m Myelofibrosis Text replacement - "back to top" to "back to top"
- 04:07, 24 October 2016 diff hist 0 m Atypical hemolytic uremic syndrome Text replacement - "back to top" to "back to top"
- 04:07, 24 October 2016 diff hist 0 m B-cell acute lymphoblastic leukemia Text replacement - "back to top" to "back to top"